A few days ago, South Africa released a study that is good news for patients with AIDS and tuberculosis. The findings, presented at this week's Seattle Retrovirus and Opportunistic Infections Conference, provide key evidence and data to address the negative interactions between HIV and tuberculosis. According to the researchers, “Pulmonary tuberculosis is a common complication for children with AIDS, but so far we don’t know if our medications are accurate, which is crucial for controlling HIV and prolonging the lives of children. Importantly, these children are often overlooked, and children with HIV are treated with limited treatment. When used with tuberculosis therapy, antiretroviral drugs cannot be used." Protease inhibitors, such as lopinavir (LPV), are key to AIDS treatment, but must be enhanced with ritonavir (RTV) to ensure that it inhibits the effects of the virus, but when the child is also receiving tuberculosis, tuberculosis The drug rifampicin reduces the concentration of RTV and affects the effectiveness of LPV. In order to solve this problem, the number of RTVs in the LPV must be increased, and this process becomes "super enhancement." The researchers said: "The purpose of this study is to provide accurate doses for medical staff to make AIDS and tuberculosis treatment effective at the same time." Silicone Gel Applicator MDK-SGA-01 China Silicone Dressing Wound,Precision Silicone Applicator,Dual Silicone Applicator,Silicone Based Dressing, we offered that you can trust. Welcome to do business with us. Silicone Dressing Wound,Precision Silicone Applicator,Dual Silicone Applicator,Silicone Based Dressing Henan Maidingkang Medical Technology Co.,Ltd , https://www.mdkmedicales.com